adenosine monophosphate has been researched along with Carcinoma, Squamous Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behrens, C; Correa, AM; Fang, B; Guo, C; Hao, C; Hofstetter, WL; Kalhor, N; Pataer, A; Roth, JA; Shao, R; Swisher, SG; Wistuba, II | 1 |
| Curtis, GL; Ryan, WL; Stenback, F | 1 |
2 other study(ies) available for adenosine monophosphate and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer.
Topics: Adenocarcinoma; Adenosine Monophosphate; Adenosine Triphosphate; AMP-Activated Protein Kinases; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; eIF-2 Kinase; Flow Cytometry; Glucose; Humans; Immunoenzyme Techniques; Lactates; Lung Neoplasms; Neoplasm Staging; Prognosis; Survival Rate; Tumor Cells, Cultured | 2015 |
Enhancement of 7,12-dimethylbenzanthracene skin carcinogenesis by adenosine 3',5'-cyclic monophosphate.
Topics: Adenosine Monophosphate; Animals; Benz(a)Anthracenes; Carcinoma, Squamous Cell; Cyclic AMP; Drug Synergism; Injections, Intraperitoneal; Mice; Mice, Inbred A; Neoplasms, Experimental; Papilloma; Skin Neoplasms | 1974 |